COLUMBUS, Ohio – The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) has earned two national awards for excellence in patient care delivery from Press Ganey, a health care performance improvement organization that works with more than 41,000 health care facilities to improve the overall safety, quality and experience of care.

This is the fourth consecutive year The James has received a Press Ganey Guardian of Excellence Award. The award recognizes top-performing health care organizations that have achieved the 95th percentile or above for performance in patient experience and is a nationally recognized symbol of achievement in health care.

Presented annually, the Guardian of Excellence Award honors health care organizations that consistently sustained performance in the top five percent of all Press Ganey clients for each reporting period over one year, as measured by the Centers for Medicare/Medicaid’s Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS).

In addition, The James received a 2019 Press Ganey Pinnacle of Excellence Award. This honor is given to top-three performing organizations in each award category. The award recognizes providers who have maintained consistently high levels of excellence over three years of patient experience, employee engagement, physician engagement and clinical quality improvement.

“These awards reaffirm that our faculty and staff are genuinely dedicated to delivering exceptional, compassionate care to our patients and their families,” says William Farrar, MD, CEO of The James Cancer Hospital and Solove Research Institute. “We are honored to serve the people of central Ohio and beyond, and will continue to strive to become even better.”

For more information about patient care at The James, visit cancer.osu.edu.

-30-

About the OSUCCC – James
The OSUCCC – James strives to create a cancer-free world by integrating scientific research with excellence in education and patient-centered care, a strategy that leads to better methods of prevention, detection and treatment. Ohio State is one of only 51 National Cancer Institute (NCI)-designated Comprehensive Cancer Centers and one of only a few centers funded by the NCI to conduct both phase I and phase II clinical trials on novel anticancer drugs sponsored by the NCI. As the cancer program’s 356-bed adult patient-care component, The James is one of the top cancer hospitals in the nation as ranked by U.S. News & World Report and has achieved Magnet® designation, the highest honor an organization can receive for quality patient care and professional nursing practice. At 21 floors and with more than 1.1 million square feet, The James is a transformational facility that fosters collaboration and integration of cancer research and clinical cancer care. For more information, visit cancer.osu.edu.

Media Contact:
Amanda J. Harper
OSUCCC – James Media Relations
614-685-5420
Amanda.Harper2@osumc.edu